You are here

  • Home
  • Archive
  • Volume 85, Issue 3
  • Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials

Article info

Article menu

Download PDFPDF

Cardiovascular medicine
Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials

Authors

  1. Professor Ramsaya.lee{at}sheffield.ac.uk
View Full Text

Citation

Sanmuganathan PS, Ghahramani P, Jackson PR, et al
Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials
Heart 2001;85:265-271.

Publication history

  • Accepted September 14, 2000
  • First published March 1, 2001.
Online issue publication 
March 01, 2001

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

British Cardiac Society